Arguably a life science company's largest asset is its IP:
Is your technology going to disrupt a major competitor with much deeper pockets?
Did you know the average cost to defend an IP infringement suit is $1.7M?
Can your balance sheet support this possibility?
Have you considered IP Insurance?